These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18690966)

  • 21. Prostanoids receptors signaling in different diseases/cancers progression.
    Yang Y; Tang LQ; Wei W
    J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiology and pathophysiology of prostanoid receptors.
    Narumiya S
    Proc Jpn Acad Ser B Phys Biol Sci; 2007 Dec; 83(9-10):296-319. PubMed ID: 24367153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs.
    Minghetti L; Polazzi E; Nicolini A; Créminon C; Levi G
    Eur J Neurosci; 1997 May; 9(5):934-40. PubMed ID: 9182946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostanoids and inflammation: a new concept arising from receptor knockout mice.
    Narumiya S
    J Mol Med (Berl); 2009 Oct; 87(10):1015-22. PubMed ID: 19609495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets.
    Samad TA; Sapirstein A; Woolf CJ
    Trends Mol Med; 2002 Aug; 8(8):390-6. PubMed ID: 12127725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
    Wang JW; Woodward DF; Martos JL; Cornell CL; Carling RW; Kingsley PJ; Marnett LJ
    FASEB J; 2016 Jan; 30(1):394-404. PubMed ID: 26420849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel CRTH2 antagonists: a review of patents from 2006 to 2009.
    Ulven T; Kostenis E
    Expert Opin Ther Pat; 2010 Nov; 20(11):1505-30. PubMed ID: 20946089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular biology and ocular distribution of prostanoid receptors.
    Woodward DF; Regan JW; Lake S; Ocklind A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S15-21. PubMed ID: 9154272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostanoid receptors and the urogenital tract.
    Breyer MD; Hébert RL; Breyer RM
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1343-53. PubMed ID: 14758774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention.
    Mutoh M; Takahashi M; Wakabayashi K
    Curr Pharm Des; 2006; 12(19):2375-82. PubMed ID: 16842185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.
    Woodward DF; Wang JW; Ni M; Bauer A; Martos JL; Carling RW; Poloso NJ
    FASEB J; 2017 Jan; 31(1):368-375. PubMed ID: 27770021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
    Hata AN; Breyer RM
    Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of diverse actions of prostanoid receptors.
    Negishi M; Sugimoto Y; Ichikawa A
    Biochim Biophys Acta; 1995 Oct; 1259(1):109-19. PubMed ID: 7492609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling.
    Fujino H
    Biol Pharm Bull; 2016; 39(2):149-55. PubMed ID: 26830476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostanoids and Hair Follicles: Implications for Therapy of Hair Disorders.
    Xu XG; Chen HD
    Acta Derm Venereol; 2018 Mar; 98(3):318-323. PubMed ID: 29136266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostanoid receptors in the human vascular wall.
    Norel X
    ScientificWorldJournal; 2007 Sep; 7():1359-74. PubMed ID: 17767355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin receptor signaling in disease.
    Matsuoka T; Narumiya S
    ScientificWorldJournal; 2007 Sep; 7():1329-47. PubMed ID: 17767353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid.
    Carlson NG
    J Neurosci Res; 2003 Jan; 71(1):79-88. PubMed ID: 12478616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.